Press releases
Press releases
Here we list English translations of the Swedish press releases published by Neola Medical AB (publ). For official press releases, please visit our Swedish website.
Neola Medical announces outcome of rights issue
This is a translation of the Swedish press release published 2022-10-20 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND,...
Neola Medical inleder biologisk utvärdering och tester inför marknadsgodkännande – erhåller anslag från Vinnova
Neola Medical AB (publ) meddelar idag att bolaget har beviljats anslag från Vinnova genom utlysningen av innovationscheckar för affärsutveckling och infrastruktur. Anslaget används för att initiera biologisk utvärdering och tester av bolagets produkt Neola®, en...
Neola Medical’s new trademark has been registered in the European Union
This is a translation of the Swedish press release published 2022-10-13 Neola Medical AB (publ) announces today that the company’s new trademark has been registered in the European Union. The new trademark is part of the company’s name change that was implemented...
New scientific article in Pediatric Research shows the benefits of the technology used by Neola Medical for continuous lung monitoring
This is a translation of the Swedish press release published 2022-10-05 A new scientific article has been published in Pediatric Research, one of the leading international pediatric journals, showing the benefits of the GASMAS-technology, used, and patented by...
Idag inleds teckningsperioden i Neola Medicals företrädesemission
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONG KONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA, SYDKOREA, ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDET, PUBLICERINGEN...
Neola Medical publishes prospectus in connection with the forthcoming rights issue
This is a translation of the Swedish press release published 2022-09-27 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND,...
Clinical study on 100 newborn babies with Neola Medical’s medical technology device completed, positive subgroup results presented
This is a translation of the Swedish press release 2022-09-21 The recruitment of 100 newborn babies to the clinical study NIOMI (Non-Invasive Lung Oxygen Monitoring in Term Infants) at University College Cork, Ireland, have now been completed. Positive subgroup...
Acquisition of IP rights, clinical study results, owner’s increased shares and the coming rights issue – CEO tells more in Neola Medicals investor letter
This is a translation of the Swedish press release 2022-09-15 In this falls investor letter (in Swedish) CEO Hanna Sjöström tells more about the upcoming rights issue that is guaranteed to 80 %, the acquisition of IP rights and the positive results from the first...
Neola Medical’s CEO Hanna Sjöström presents at ABG Sundal Colliers Investor Day the 13th of September
This is a translation of the Swedish press release published 2022-09-12 Neola Medical AB (publ) will participate at ABG Sundal Colliers Investor Day in Stockholm the 13th of September and present the company. At 15.00 (3 pm) CEO Hanna Sjöström will present the...
Neola Medical AB: Notice of extraordinary general meeting in Neola Medical AB
This is a translation of the Swedish press release 2022-09-08 Shareholders in Neola Medical AB, org.nr 559069–9012 (”the Company”), are hereby given notice of the extraordinary general meeting the 27th of September 2022. The board of directors has decided in...